Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry Based Randomized Controlled Trial of Multiple Combination Strategies of Intensive Glycemic Control to Reduce a Composite of Macrovascular and Microvascular Events in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH Study)

NCT06627322 is registered in ClinicalTrials.gov with Kyu Chang Won as lead sponsor.

NCT NCT06627322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06627322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry Based Randomized Controlled Trial of Multiple Combination Strategies of Intensive Glycemic Control to Reduce a Composite of Macrovascular and Microvascular Events in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH Study)
Lead sponsor
Kyu Chang Won
Phase
Not applicable
Overall status
Recruiting
Start date
November 21, 2024
Completion date
September 30, 2029
Enrollment
5,950 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes